APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)

Clinical trial NCT03997383 · COMPLETED

Trial details

NCT number: NCT03997383
Sponsor: Alnylam Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Transthyretin Amyloidosis (ATTR) With Cardiomyopathy

Start date: 2019-09-04
Primary completion: 2022-06-20
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.